ARMISTICE CAPITAL, LLC

Q1 2021 13F-HR Holdings

Location
New York, NY
Holdings as of
3/31/2021
Date filed
5/17/2021
Form type
13F-HR
Num holdings
111
Total value ($000)
$4,355,444
Net value change ($000)
+2,120,620 (94.9%)
New positions
35
Sold out positions
33
Turnover %
37.3%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Prev filing: 2/16/2021 Next filing: 8/16/2021 SEC filing

Snapshot: Change Analysis

Compared to Q4 2020
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
VRTX 84,237 NEW
TJX 74,625 NEW
AMZN 60,742 365.7%
TVTX 58,829 NEW
AAP 50,179 NEW
BUD 43,995 NEW
PFE 43,476 NEW
NKE 42,856 NEW
Ortho Clinical Diagnostics Holdings plc 42,372 NEW
CLX 36,105 298.0%
Top Reduces (Value $000, Stocks/ETFs)
ORLY -40,995 -100.0%
ULTA -39,715 -100.0%
FIVE -34,182 -72.8%
FTDR -32,938 -100.0%
AZO -32,705 -100.0%
TGT -31,544 -100.0%
ROST -26,071 -100.0%
BURL -25,486 -100.0%
Grayscale Funds Trust -21,128 -100.0%
BGS -20,560 -69.7%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 1,234,540 (28.3% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type